Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - RESEARCH & DEVELOPMENT
Research & Development ELVN - Enliven Therapeutics, Inc.
64.6 M
LAST VALUE
77.59%
2 YEAR CAGR
50.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR